Expert Perspectives on Advances in Precision Medicine in Treating Rheumatoid Arthritis

home / insights / expert-perspectives-on-advances-in-precision-medicine-in-treating-rheumatoid-arthritis

An expert rheumatologist reviews current treatment options in rheumatoid arthritis, focusing on tumor necrosis factor-α inhibitors (TNFi) and the molecular signature response classifier (MSRC) test.

Treatment Options for Rheumatoid Arthritis (RA)

EP. 1: Treatment Options for Rheumatoid Arthritis (RA)

February 28th 2023

Vibeke Strand, MD, MACR, FACP, provides an overview of treatment options for rheumatoid arthritis.

Role of Tumor Necrosis Factor-α Inhibitors (TNFi) in RA Treatment

EP. 2: Role of Tumor Necrosis Factor-α Inhibitors (TNFi) in RA Treatment

February 28th 2023

Dr Vibeke Strand highlights the use of tumor necrosis factor inhibitors in the treatment of RA.

Tools for Improving Treatment Selection in RA

EP. 3: Tools for Improving Treatment Selection in RA

March 7th 2023

Vibeke Strand, MD, MACR, FACP, reviews the tools available to clinicians to improve treatment selection in RA, focusing on the molecular signature response classifier test.

AIMS Study and Comparative Cohort Study of the MSRC Test in RA

EP. 4: AIMS Study and Comparative Cohort Study of the MSRC Test in RA

March 7th 2023

An expert rheumatologist discusses the Accelerate Information of Molecular Signatures (AIMS) study and the comparative cohort study of the MSRC test.

Improving Management of RA

EP. 5: Improving Management of RA

March 7th 2023

Vibeke Strand, MD, MACR, FACP, shares the advantages and limitations of the AIMS and comparative cohort studies in the treatment of RA.

© 2024 MJH Life Sciences

All rights reserved.